Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Cardiol Therapeutics Inc (CRDL.TO)
Cardiol Therapeutics Inc (CRDL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 57,688
  • Shares Outstanding, K 64,098
  • Annual Sales, $ 0 K
  • Annual Income, $ -30,931 K
  • 60-Month Beta 0.22
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.27
Trade CRDL.TO with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.46
  • Most Recent Earnings -0.11 on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.74 +21.62%
on 05/16/23
1.00 -10.00%
on 05/24/23
+0.07 (+8.43%)
since 05/02/23
3-Month
0.61 +47.54%
on 04/05/23
1.00 -10.00%
on 05/24/23
+0.18 (+25.00%)
since 03/02/23
52-Week
0.61 +47.54%
on 04/05/23
2.14 -57.94%
on 06/28/22
-0.74 (-45.12%)
since 06/02/22

Most Recent Stories

More News
Cardiol Therapeutics Announces Year-End 2022 Update on Operations

Initiated patient enrollment in a Phase II open-label clinical trial investigating the safety, tolerability, and efficacy of CardiolRx™ in patients with recurrent pericarditis - a debilitating heart...

CRDL.TO : 0.90 (unch)
CRDL : 0.6681 (+0.23%)
Cardiol Therapeutics Announces Study Results from Collaborating Research Center Demonstrating Cardioprotective Effects of Cannabidiol in a Model of Heart Failure

Results Demonstrate Cannabidiol Improved Cardiac Function, Reduced its Inflammatory State, and Prevented the Development of Hypertrophy and Fibrosis in Heart TissueData Presented at The American College...

CRDL.TO : 0.90 (unch)
CRDL : 0.6681 (+0.23%)
Cardiol Therapeutics Announces First Patient Enrolled in Phase II Study Evaluating CardiolRx(TM) for the Treatment of Recurrent Pericarditis

The Cleveland Clinic Recruits First Participant in the Multi-center U.S. StudyOakville, Ontario--(Newsfile Corp. - January 17, 2023) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or...

CRDL.TO : 0.90 (unch)
CRDL : 0.6681 (+0.23%)
Stocks in play: Cardiol Therapeutics Inc

Announces the initiation of a Phase II open-label pilot study (NCT05494788), to investigate the tolerance, ...

CRDL.TO : 0.90 (unch)
Hot Debate Over Myocarditis Risk Shines Spotlight on Heart Disease

Palm Beach, FL – July 26, 2022 – FinancialNewsMedia.com News Commentary – As COVID-19 vaccines for kids achieve the Centers for Disease Control and Prevention (CDC) recommendation, concern it could...

CRDL : 0.6681 (+0.23%)
CRDL.TO : 0.90 (unch)
JNJ : 156.97 (+1.57%)
TAK : 16.12 (+1.45%)
NVO : 157.14 (-0.53%)
BMY : 65.66 (+1.52%)
Hot Debate Over Myocarditis Risk Shines Spotlight on Heart Disease

/PRNewswire/ -- As COVID-19 vaccines for kids achieve the Centers for Disease Control and Prevention (CDC) recommendation, the concern that it could increase...

CRDL.TO : 0.90 (unch)
JNJ : 156.97 (+1.57%)
TAK : 16.12 (+1.45%)
NVO : 157.14 (-0.53%)
BMY : 65.66 (+1.52%)
CRDL : 0.6681 (+0.23%)
Air Pollution is a Global Heart and Lung Health Concern

/PRNewswire/ -- Particulate matter or particle pollution is a significant contributor to heart and lung disease. Individuals most affected by poor air quality...

CRDL.TO : 0.90 (unch)
GSK : 34.11 (+0.92%)
AZN : 72.59 (-0.34%)
REGN : 739.95 (+1.20%)
CRDL : 0.6681 (+0.23%)
Air Pollution is a Global Heart and Lung Health Concern

Palm Beach, FL – July 18, 2022 – FinancialNewsMedia.com News Commentary – Particulate matter or particle pollution is a significant contributor to heart and lung disease. Individuals most affected...

CRDL : 0.6681 (+0.23%)
CRDL.TO : 0.90 (unch)
GSK : 34.11 (+0.92%)
AZN : 72.59 (-0.34%)
REGN : 739.95 (+1.20%)
The Healthcare Companies Fighting the World’s Biggest Killers

Palm Beach, FL – July 13, 2022 – FinancialNewsMedia.com News Commentary – Some of the most prevalent health conditions on the planet claim millions of lives every year. Companies from across the...

CRDL : 0.6681 (+0.23%)
CRDL.TO : 0.90 (unch)
VRNA : 21.46 (-1.92%)
PODD : 281.03 (+3.14%)
NVS : 98.91 (+1.85%)
The Healthcare Companies Fighting the World's Biggest Killers

/PRNewswire/ -- Some of the most prevalent health conditions on the planet claim millions of lives every year. Companies from across the healthcare sector are...

CRDL.TO : 0.90 (unch)
VRNA : 21.46 (-1.92%)
PODD : 281.03 (+3.14%)
NVS : 98.91 (+1.85%)
CRDL : 0.6681 (+0.23%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Key Turning Points

3rd Resistance Point 0.95
2nd Resistance Point 0.93
1st Resistance Point 0.92
Last Price 0.90
1st Support Level 0.89
2nd Support Level 0.87
3rd Support Level 0.86

See More

52-Week High 2.14
Fibonacci 61.8% 1.56
Fibonacci 50% 1.38
Fibonacci 38.2% 1.19
Last Price 0.90
52-Week Low 0.61

See More

Business Summary

Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's lead product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol...

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar